Iyza F. Baig


Considering use of teprotumumab in thyroid eye disease patients

There is need for alternative treatment to circumvent current treatment limitations

When autoimmune diseases exert neuro-ophthalmic effects

Treatment should focus on the underlying etiology behind these processes

Exploring tocilizumab for giant cell arteritis cases

New content coming soon, please check back later.